Insider Trading: CytRx Corp (CYTR.PH)
CYTR.PH on Philadelphia Stock Exchange
2.45USD
11:11am EDT
2.45USD
11:11am EDT
Price Change (% chg)
$0.04 (+1.66%)
$0.04 (+1.66%)
Prev Close
$2.41
$2.41
Open
$2.45
$2.45
Day's High
$2.45
$2.45
Day's Low
$2.45
$2.45
Volume
100
100
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
| KRIEGSMAN STEVEN A | Options Exercised: 0 | ||
| Trade Date: | Tuesday, 21 Feb 2012 | Price: | 0.31 |
| Title: | Chief Executive Officer | Shares Held: | 4,179,776 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 158,676 |
Institutional Holders
| % Shares Owned: | 11.01% |
| # of Holders: | 38 |
| Total Shares Held: | 3,359,717 |
| 3 Mo. Net Change: | -238,023 |
| # New Positions: | 8 |
| # Closed Positions: | 4 |
| # Increased Positions: | 16 |
| # Reduced Positions: | 7 |
| # Net Buyers: | 9 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Max Link |
72 | 2002 | Independent Chairman of the Board |
Steven Kriegsman |
71 | 2002 | President, Chief Executive Officer, Director |
Marvin Selter |
85 | 2004 | Independent Vice Chairman of the Board |
John Caloz |
61 | 2009 | Chief Financial Officer |
Daniel Levitt |
65 | 2013 | Executive Vice President, Chief Medical Officer |
Douglas Wieland |
53 | 2008 | Senior Vice President - Drug Development |
Benjamin Levin |
36 | 2004 | Vice President - Legal Affairs, General Counsel, Corporate Secretary |
David Haen |
34 | 2007 | Vice President - Business Development |
Louis Ignarro |
71 | 2002 | Independent Director |
Joseph Rubinfeld |
80 | 2002 | Independent Director |
Richard Wennekamp |
70 | 2003 | Independent Director |
Thomas Wagner |
IR Contact |

